Protalix BioTherapeutics Inc. (DE)

Last updated September 27, 2026

Organization details

Legal name
Protalix BioTherapeutics Inc. (DE)
Former names
Orthodontix Inc Embassy Acquisition Corp
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation
Delaware
Headquarters city
Hackensack
Headquarters state / province
New Jersey
Headquarters country
Israel
Fiscal year end
December
Ticker symbol
PLX
Primary stock exchange
NYSE American

Identifiers

SEC CIK
0001006281
EIN
65-0643773

Board of directors

Chief executives

Dror Bashan · President and CEO
Dates unknown

Director election results

Annual meeting of June 25, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

3 of this board's directors also sit on 5 other boards. 5 are in the same sector.

Network of Protalix BioTherapeutics Inc. (DE)'s board connections BioLineRx Ltd. BioLineRx Ltd. Chemomab Therapeutics Ltd. American Depositary Share Chemomab Therapeutics... Collegium Pharmaceutical Inc. Collegium Pharmaceutic... Gain Therapeutics Inc. Gain Therapeutics Inc. Immatics N.V. Immatics N.V. Aharon Schwartz Aharon Schwartz Eliot Forster Eliot Forster Gwen A. Melincoff Gwen A. Melincoff Protalix BioTherapeutics I...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$101,360
1 purchase by 1 insider
Sold, last 12 months
$314
1 sale by 1 insider
Date Insider Transaction Shares Price Value
Dec 19, 2025 Dror Bashan Director, Officer (PRESIDENT AND CEO) Open-market purchase +56,000 $1.81 $101,360
Nov 18, 2025 Amos Bar-Shalev Director Open-market sale −168 $1.87 $314
Sep 3, 2025 Eliot Forster Director Grant or award +7,500 — —
Sep 3, 2025 Christian Elze Director Grant or award +7,500 — —
Sep 3, 2025 Gwen A. Melincoff Director Grant or award +7,500 — —
Sep 3, 2025 Pol F. Boudes Director Grant or award +7,500 — —
Sep 3, 2025 Aharon Schwartz Director Grant or award +7,500 — —
Sep 3, 2025 Zvi Shmuel Ben Director Grant or award +7,500 — —
Sep 3, 2025 Amos Bar-Shalev Director Grant or award +7,500 — —
Sep 3, 2025 Naos Yaron Officer (Sr. VP, Operations) Grant or award +25,000 — —
Sep 3, 2025 Dror Bashan Director, Officer (PRESIDENT AND CEO) Grant or award +195,000 — —
Jun 10, 2025 Aharon Schwartz Director Open-market purchase +129,000 $1.60 $206,400
Sep 23, 2024 Rubin Eyal Officer (Sr. VP and CFO) Grant or award +99,010 — —
Apr 1, 2024 Dror Bashan Director, Officer (PRESIDENT AND CEO) Grant or award +263,960 — —
Oct 19, 2023 Dror Bashan Director, Officer (PRESIDENT AND CEO) Open-market purchase +48,387 $1.40 $67,742

Organizations in the same sector, closest in location and size first.

Questions about Protalix BioTherapeutics Inc. (DE)

Who is the CEO of Protalix BioTherapeutics Inc. (DE)?

Dror Bashan is Protalix BioTherapeutics Inc. (DE)'s President and CEO.

How many directors are on Protalix BioTherapeutics Inc. (DE)'s board?

Protalix BioTherapeutics Inc. (DE)'s board has 8 directors: Aharon Schwartz, Amos Bar-Shalev, Christian Elze, Dror Bashan, Eliot Forster, Gwen A. Melincoff, Pol F. Boudes and Zvi Shmuel Ben.

Are Protalix BioTherapeutics Inc. (DE) insiders buying or selling shares?

Over the last 12 months, Protalix BioTherapeutics Inc. (DE) insiders bought $101,360 of shares in 1 purchase and sold $314 of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="protalix-biotherapeutics-inc-de"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.